Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 3/20 | 0.43 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | MIF | P14174 | 3/20 | 0.41 |
| ▸ | CD74 | P04233 | 1/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.39 |
| ▸ | AOC2 | O75106 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL30801353 | 0.93 | NOTUM (0.38) | MAOANOTUML3MBTL1NPC1MIF | |
| Formic Acid SCHEMBL30801354 | 0.93 | NOTUM (0.38) | MAOANOTUML3MBTL1NPC1MIF | |
| SCHEMBL23326579 | 0.85 | GLA (0.46) | MAOANOTUML3MBTL1NPC1MIF | |
| SCHEMBL26087979 | 0.79 | NPSR1 (0.56) | L3MBTL1AOC2MEN1KMT2AALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL30801355 | 0.77 | MIF (0.43) | MAOANOTUML3MBTL1NPC1MIF | |
| SCHEMBL23326867 | 0.73 | ALDH1A1 (0.40) | L3MBTL1AOC2POLBKDM4EALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL23326865 | 0.72 | L3MBTL1 (0.43) | NOTUML3MBTL1NPC1MIFAPP | |
| Formic Acid SCHEMBL30219804 | 0.71 | NPSR1 (0.48) | L3MBTL1AOC2CA1CA2MEN1 | |
| Trifluoroacetic Acid SCHEMBL30801352 | 0.71 | MIF (0.45) | MAOANOTUML3MBTL1NPC1MIF | |
| SCHEMBL30801359 | 0.70 | L3MBTL1 (0.55) | MAOANOTUML3MBTL1NPC1MIF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11885818-B2 | Reagent for mass spectrometry | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2024-01-30 | — | — | US | disclosed |
| US-20210140983-A1 | REAGENT FOR MASS SPECTROMETRY | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2021-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210140983-A1 | REAGENT FOR MASS SPECTROMETRY | SRMS, PTMS, MMAB | MAOA 854/4885NOTUM 212/4885L3MBTL1 2526/4885 |
| US-11885818-B2 | Reagent for mass spectrometry | SRMS, PTMS, MMAB | MAOA 854/4885NOTUM 212/4885L3MBTL1 2526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.